Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

SANUWAVE Health (SNWV) Research & Development (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Research & Development for 8 consecutive years, with $345000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Research & Development rose 114.29% to $345000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $901000.0, a 7.66% decrease, with the full-year FY2024 number at $673000.0, up 16.23% from a year prior.
  • Research & Development was $345000.0 for Q3 2025 at SANUWAVE Health, up from $194000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $345000.0 in Q3 2025 to a low of $154000.0 in Q4 2024.